Berlin - Delayed Quote EUR
Collegium Pharmaceutical Inc (354.BE)
24.00
+0.60
+(2.56%)
As of 8:13:04 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
631,449
631,449
566,767
463,933
276,868
Cost of Revenue
254,105
254,105
240,598
254,445
126,251
Gross Profit
377,344
377,344
326,169
209,488
150,617
Operating Expense
210,363
210,363
159,208
176,169
128,411
Operating Income
166,981
166,981
166,961
33,319
22,206
Net Non Operating Interest Income Expense
-59,998
-59,998
-67,724
-62,166
-21,002
Other Income Expense
-8,415
-8,415
-23,504
--
-4,578
Pretax Income
98,568
98,568
75,733
-28,847
-3,374
Tax Provision
29,378
29,378
27,578
-3,845
-74,891
Net Income Common Stockholders
69,190
69,190
48,155
-25,002
71,517
Average Dilution Earnings
5,863
5,863
5,889
--
4,675
Diluted NI Available to Com Stockholders
75,053
75,053
54,044
-25,002
76,192
Basic EPS
2.71
2.14
1.43
-0.74
2.05
Diluted EPS
2.34
1.86
1.29
-0.74
1.86
Basic Average Shares
32,325.90
32,273.85
33,741.21
33,829.50
34,936.82
Diluted Average Shares
45,726.62
40,424.18
41,788.13
33,829.50
41,045.81
Total Operating Income as Reported
169,895
169,895
166,961
33,319
17,628
Total Expenses
464,468
464,468
399,806
430,614
254,662
Net Income from Continuing & Discontinued Operation
69,190
69,190
48,155
-25,002
71,517
Normalized Income
75,097.33
75,097.33
63,103.54
-25,002
74,858.94
Interest Income
13,976
13,976
15,615
1,047
12
Interest Expense
73,974
73,974
83,339
63,213
21,014
Net Interest Income
-59,998
-59,998
-67,724
-62,166
-21,002
EBIT
172,542
172,542
159,072
34,366
17,640
EBITDA
341,702
341,702
308,328
173,305
86,557
Reconciled Cost of Revenue
254,105
254,105
240,598
254,445
126,251
Reconciled Depreciation
169,160
169,160
149,256
138,939
68,917
Net Income from Continuing Operation Net Minority Interest
69,190
69,190
48,155
-25,002
71,517
Total Unusual Items Excluding Goodwill
-8,415
-8,415
-23,504
--
-4,578
Total Unusual Items
-8,415
-8,415
-23,504
--
-4,578
Normalized EBITDA
350,117
350,117
331,832
173,305
91,135
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,507.67
-2,507.67
-8,555.46
--
-1,236.06
12/31/2021 - 3/23/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade